COLL vs WFC · P/E 17, rev $181.9M vs P/E 15, $272.05B cap
Collegium Pharmaceutical Inc (COLL) versus Wells Fargo & Company (WFC) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Wells Fargo & Company (WFC) is a banks - diversified company listed on US. It is led by Charlie Scharf.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
WFC does not have a complete income-statement cache yet.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
Not investment advice. Open the COLL and WFC stock pages for the full models.
Not investment advice.